Insider transactions

EDGAR

Aligos Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–10 of 10

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-06-25 Filed 2026-06-29Nuechterlein Carole Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (5,860) — exercise price 5.5
Acquired (A)5,8600—5,860Direct (D) No
F1
  • F1 The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2027 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.
Open filing 0001610717-26-000301 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Scopa James Paul Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (5,860) — exercise price 5.5
Acquired (A)5,8600—5,860Direct (D) No
F1
  • F1 The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2027 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.
Open filing 0001610717-26-000302 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Martell Bridget A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (5,860) — exercise price 5.5
Acquired (A)5,8600—5,860Direct (D) No
F1
  • F1 The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2027 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.
Open filing 0001610717-26-000303 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Hirth Peter Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (5,860) — exercise price 5.5
Acquired (A)5,8600—5,860Direct (D) No
F1
  • F1 The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2027 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.
Open filing 0001610717-26-000300 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Preston Heather Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (5,860) — exercise price 5.5
Acquired (A)5,8600—5,860Direct (D) No
F1
  • F1 The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2027 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.
Open filing 0001610717-26-000305 Read from the filing’s XML Dispute this row
2026-06-25 Filed 2026-06-29Chavez Margarita Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (5,860) — exercise price 5.5
Acquired (A)5,8600—5,860Direct (D) No
F1
  • F1 The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2027 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.
Open filing 0001610717-26-000304 Read from the filing’s XML Dispute this row
2026-03-09 Filed 2026-03-11Aneja Nikhil Officer: Principal Accounting Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (9,450) — exercise price 7.03
Acquired (A)9,4500—9,450Direct (D) No
F1
  • F1 1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from March 9, 2026 (the Vesting Commencement Date), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Open filing 0001610717-26-000094 Read from the filing’s XML Dispute this row
2026-03-09 Filed 2026-03-11Calhoun Lesley Ann Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (37,485) — exercise price 7.03
Acquired (A)37,4850—37,485Direct (D) No
F1
  • F1 1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from March 9, 2026 (the Vesting Commencement Date), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Open filing 0001610717-26-000093 Read from the filing’s XML Dispute this row
2026-03-09 Filed 2026-03-11Symons Julian A. Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (23,310) — exercise price 7.03
Acquired (A)23,3100—23,310Direct (D) No
F1
  • F1 1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from March 9, 2026 (the Vesting Commencement Date), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Open filing 0001610717-26-000095 Read from the filing’s XML Dispute this row
2026-03-09 Filed 2026-03-11BLATT LAWRENCE Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (105,840) — exercise price 7.03
Acquired (A)105,8400—105,840Direct (D) No
F1
  • F1 1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from March 9, 2026 (the Vesting Commencement Date), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Open filing 0001610717-26-000092 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–36 of 36

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Deep Track Capital, LP 444,110 SH2,500,339 dollarsUnchanged Prior quarter: 444,110Open filing 0001856083-26-000006 Filed 2026-11-16 Dispute this row
Sio Capital Management, LLC 327,237 SH1,842,344 dollarsUnchanged Prior quarter: 327,237Open filing 0001214659-26-014302 Filed 2026-11-16 Dispute this row
Parkman Healthcare Partners LLC 325,537 SH1,832,773 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002809 Filed 2026-11-16 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager246,579 SH1,388,239 dollarsUnchanged Prior quarter: 246,579Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
Schonfeld Strategic Advisors LLC 181,880 SH1,023,984 dollarsNot in the prior quarter’s filings read Open filing 0001665241-26-000003 Filed 2026-11-16 Dispute this row
Woodline Partners LP 177,362 SH998,548 dollarsUnchanged Prior quarter: 177,362Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 175,543 SH988,307 dollarsUnchanged Prior quarter: 175,543Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
BAKER BROS. ADVISORS LP 83,055 SH467,600 dollarsUnchanged Prior quarter: 83,055Open filing 0001104659-26-128308 Filed 2026-11-16 Dispute this row
HHLR ADVISORS, LTD. Partly reported under another manager76,247 SH429,271 dollarsUnchanged Prior quarter: 76,247Open filing 0000919574-26-008150 Filed 2026-11-16 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager71,528 SH402,703 dollarsHigher by 5,065 Prior quarter: 66,463Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager67,298 SH378,888 dollarsHigher by 7,312 Prior quarter: 59,986Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager50,310 SH283,375 dollarsHigher by 3,137 Prior quarter: 47,173Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
PRUDENTIAL FINANCIAL INC Partly reported under another manager45,354 SH255,343 dollarsNot in the prior quarter’s filings read Open filing 0001137774-26-000233 Filed 2026-11-16 Dispute this row
LPL Financial LLC 38,170 SH214,897 dollarsNot in the prior quarter’s filings read Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row
BlackRock, Inc. Partly reported under another manager29,536 SH166,288 dollarsLower by 756 Prior quarter: 30,292Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 28,612 SH161,086 dollarsUnchanged Prior quarter: 28,612Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
TWO SIGMA INVESTMENTS, LP 27,522 SH154,949 dollarsNot in the prior quarter’s filings read Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager21,044 SH118,478 dollarsUnchanged Prior quarter: 21,044Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
GSA CAPITAL PARTNERS LLP 20,714 SH117 dollarsNot in the prior quarter’s filings read Open filing 0001362033-26-000013 Filed 2026-11-16 Dispute this row
Trexquant Investment LP Partly reported under another manager19,395 SH109,194 dollarsHigher by 7,056 Prior quarter: 12,339Open filing 0001633445-26-000008 Filed 2026-11-16 Dispute this row
Verition Fund Management LLC 18,887 SH106,334 dollarsUnchanged Prior quarter: 18,887Open filing 0001454027-26-000007 Filed 2026-11-13 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager15,100 SH85,013 dollarsHigher by 4,300 Prior quarter: 10,800Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
Quadrature Capital Ltd Partly reported under another manager13,406 SH75,476 dollarsNot in the prior quarter’s filings read Open filing 0001651424-26-000014 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager11,539 SH64,965 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Rockefeller Capital Management L.P. Partly reported under another manager10,276 SH57,854 dollarsHigher by 276 Prior quarter: 10,000Open filing 0001739439-26-000009 Filed 2026-11-13 Dispute this row
Federation des caisses Desjardins du Quebec Partly reported under another manager3,300 SH18,579 dollarsLower by 1,350 Prior quarter: 4,650Open filing 0002022297-26-000010 Filed 2026-11-16 Dispute this row
Golden State Wealth Management, LLC 2,674 SH15,055 dollarsUnchanged Prior quarter: 2,674Open filing 0001776033-26-000006 Filed 2026-11-02 Dispute this row
ROYAL BANK OF CANADA Partly reported under another manager2,231 SH13,000 dollarsHigher by 106 Prior quarter: 2,125Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager205 SH1,154 dollarsHigher by 1 Prior quarter: 204Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
OSAIC HOLDINGS, INC. Partly reported under another manager200 SH1,124 dollarsNot in the prior quarter’s filings read Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager26 SH146 dollarsLower by 318 Prior quarter: 344Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
SBI Securities Co., Ltd. 26 SH146 dollarsLower by 100 Prior quarter: 126Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager5 SH28 dollarsLower by 354 Prior quarter: 359Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
ELEVATION WEALTH PARTNERS, LLC 4 SH23 dollarsUnchanged Prior quarter: 4Open filing 0001976256-26-000006 Filed 2026-10-07 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager3 SH17 dollarsUnchanged Prior quarter: 3Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
BARCLAYS PLC Partly reported under another manager1 SH6 dollarsNot in the prior quarter’s filings read Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Alyeska Investment Group, L.P. 412,000 SH
  • JANE STREET GROUP, LLC 32,402 SH
  • CITIGROUP INC 1,808 SH
  • WELLS FARGO COMPANY/MN 100 SH
  • FMR LLC 10 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Alyeska Investment Group, L.P. Common Stock, par value, $0.0001 per share5.64352,472.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-005360 Dispute this row
Alyeska Fund GP, LLC Common Stock, par value, $0.0001 per share5.64352,472.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-005360 Dispute this row
Anand Parekh Common Stock, par value, $0.0001 per share5.64352,472.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-005360 Dispute this row
Parkman Healthcare Partners LLC Common Stock par value, $0.0001 per share5.2325,537.0009/30/2026 Filed 2026-11-13SCHEDULE 13GOpen filing 0000919574-26-007697 Dispute this row
Parkman Healthcare Partners Holdings LP Common Stock par value, $0.0001 per share5.2325,537.0009/30/2026 Filed 2026-11-13SCHEDULE 13GOpen filing 0000919574-26-007697 Dispute this row
Parkman Healthcare Partners Holdings GP LLC Common Stock par value, $0.0001 per share5.2325,537.0009/30/2026 Filed 2026-11-13SCHEDULE 13GOpen filing 0000919574-26-007697 Dispute this row
Gregory Martinez Common Stock par value, $0.0001 per share5.2325,537.0009/30/2026 Filed 2026-11-13SCHEDULE 13GOpen filing 0000919574-26-007697 Dispute this row
Lawrence M. Blatt Common Stock, par value, $0.0001 per share5.6316,22806/16/2026 Filed 2026-06-24SCHEDULE 13DOpen filing 0001193125-26-281134 Dispute this row
Lawrence M. Blatt Common Stock, par value, $0.0001 per share5.1286,21303/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001193125-26-226938 Dispute this row
Woodline Partners LP Voting Common Stock, par value $0.0001 per share4.4239,362.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 4Open filing 0000919574-26-003231 Dispute this row
Woodline Partners LP Voting Common Stock, par value $0.0001 per share5.4289,169.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 3Open filing 0000902664-26-001065 Dispute this row
Sio Capital Management, LLC Common Stock, par value, $0.0001 per share5.46335,937.0012/31/2025 Filed 2026-02-11SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-001502 Dispute this row
Woodline Partners LP Voting Common Stock, par value $0.0001 per share8.7468,199.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0000902664-25-005026 Dispute this row
Woodline Partners LP Voting Common Stock, par value $0.0001 per share9.8518,300.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-003590 Dispute this row
Sio Capital Management, LLC Common Stock, par value, $0.0001 per share5.49355,937.0006/30/2025 Filed 2025-08-13SCHEDULE 13GOpen filing 0001214659-25-011951 Dispute this row
Adage Capital Management, L.P. Voting Common Stock, par value $0.0001 per share3.90210,000.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 2Open filing 0000902664-25-003496 Dispute this row
Robert Atchinson Voting Common Stock, par value $0.0001 per share3.90210,000.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 2Open filing 0000902664-25-003496 Dispute this row
Phillip Gross Voting Common Stock, par value $0.0001 per share3.90210,000.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 2Open filing 0000902664-25-003496 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,655,474 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201572,561
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,123

Filings made before the SEC required XML are listed, not extracted.

Back to Aligos Therapeutics, Inc.